insights_auto
Prečo akcie ALMKT klesli 4,22%?
Preskúmať podrobnejšiechevron_right
ALMKT:EPA
Mauna Kea Technologies SA
0,089 €
arrow_downward
-4,22%(-0,0039) 1 d.
18. 11., 17:35:09 GMT+1 · EUR
search
Všetky symboly
| Symbol | Cena | Zmena | % zmeny |
|---|
insights_autoGenerujú sa najdôležitejšie štatistiky pre ALMKT…
Otvoriť
0,09 €
Vysoká
0,09 €
Nízka
0,09 €
Trh. kap.
17,68 mil.
Priem. obj.
481,42 tis.
Objem
152,44 tis.
Pomer cena/zárobky
0,75
Max. za 52 týž.
0,23 €
Min. za 52 týž.
0,07 €
Výnosy na akciu
0,12 €
Akcie v obehu
195,26 mil.
Počet zamestnancov
56
Otvoriť
0,09 €
Vysoká
0,09 €
Nízka
0,09 €
Trh. kap.
17,68 mil.
Priem. obj.
481,42 tis.
Objem
152,44 tis.
Pomer cena/zárobky
0,75
Max. za 52 týž.
0,23 €
Min. za 52 týž.
0,07 €
Výnosy na akciu
0,12 €
Akcie v obehu
195,26 mil.
Počet zamestnancov
56
Spravodajstvo
Z internetových zdrojov a od spravodajských partnerov
Yahoo Finance
·
pred 1 hodinou
Nasdaq, Dow, S&P 500 Futures Climb Ahead Of Anthropic’s Record Debut: SLS, GLD, TTWO, UNH In Focus
Barron's
·
pred 5 hodinami
Generac Jolted After Nvidia Earnings. Why It’s a Top S&P 500 Stock Today.
The Motley Fool
·
pred 1 hodinou
The S&P 500 Just Ended a Run of 155 Trading Days Above Its 200-Day Average. Here's What Followed 34 Similar Runs Since 1950.
Hedgeye
·
pred 15 hodinami
Why Negative Gamma Has Taken the Brakes Off the S&P 500
Profil
Mauna Kea Technologies is a global medical device company focused on endomicroscopy, the field of microscopic imaging during endoscopy procedures. The company researches, develops and markets tools to visualize, detect, and rule out abnormalities including malignant and pre-malignant tumors or lesions in the gastrointestinal and pulmonary tracts.
The company makes Cellvizio, a probe-based Confocal Laser Endomicroscopy system, which provides physicians and researchers with real-time access to histological information during standard endoscopy procedures through high-resolution cellular imaging of internal tissues.
Cellvizio is used in medical applications such as gastrointestinal endoscopy, pulmonology and urology to help physicians diagnose lesions and make accurate treatment decisions in real-time.
Cellvizio went public in July 2011 and trades on the Euronext Paris exchange. Wikipedia
Informácie o subjekte Mauna Kea Technologies SA
Generálny riaditeľSacha Loiseau
Zamestnanci56
Dátum založenia2000
Hlavné sídlo-
OdvetvieHealth Care
Odvetvie-